Radford joins Nanosonics
Thursday, 05 June, 2008
Nanosonics Ltd (ASX: NAN) has appointed a new CEO to lead the disinfection technology company's latest product roll-out.
The new CEO, David Radford, has 20 years of experience in the medical device and healthcare industries. He also has an honours degree in applied biological science from Bristol Polytechnic.
The company said Radford has extensive experience driving rapid growth in the ultrasound product market, which makes him the perfect person to oversee the company's roll-out of its new ultrasound disinfection devices.
Radford takes the helm from Nanosonics CFO Chris Grundy, who had been acting as CEO, and from Dr David Fisher, who had taken on the role of interim executive director.
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
Portable point-of-care test detects four common STIs in under an hour
Australian researchers have developed a portable point-of-care test that detects four common...
AusBiotech and Proto Axiom partner on investor-focused life sciences programs
AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...
